Skip to search formSkip to main contentSkip to account menu

Ventricular Assist Device Placement

A surgical procedure in which a mechanical pump is implanted to enhance the function of the left or right heart ventricle.
National Institutes of Health

Related topics

Related topics

1 relation
Cardiovascular system

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis
Importance Vasopressin is an alternative to catecholamine vasopressors for patients with distributive shock—a condition due to… 
Highly Cited
2015
Highly Cited
2015
Long-term risk of recurrence, morbidity and mortality in giant cell myocarditis.
Highly Cited
2013
Highly Cited
2013
Clinical Investigations Postoperative Right Ventricular Failure After Left Ventricular Assist Device Placement is Predicted by Preoperative Echocardiographic Structural, Hemodynamic, and Functional…
Background: Right ventricular failure (RVF) after left ventricular assist device (LVAD) implantation results in significant… 
Review
2012
Review
2012
The Spectrum of Complications Following Left Ventricular Assist Device Placement
Abstract  Introduction: Left ventricular assist device (LVAD) support is associated with many complications, but relatively few… 
Highly Cited
2011
Highly Cited
2011
Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support.
Review
2008
Review
2008
Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.
Highly Cited
2004
Highly Cited
2004
Heart failure survival score continues to predict clinical outcomes in patients with heart failure receiving beta-blockers.
Highly Cited
1998
Highly Cited
1998
Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent.
Highly Cited
1997
Highly Cited
1997
A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement.
BACKGROUND Vasodilatory shock requiring catecholamine pressors occurs in some patients following cardiopulmonary bypass. Prompted… 
Highly Cited
1995
Highly Cited
1995
Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)